Tech Company M&A Transactions
FoldRx Pharmaceuticals Acquisition
FoldRx Pharmaceuticals, operating out of Cambridge, was acquired by Pfizer. No transaction price was released.
Transaction Overview
Company Name
Acquired By
Announced On
9/1/2010
Transaction Type
M&A
Amount
Unknown
M&A Terms
Terms of the transaction were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
100 Acorn Park Drive 5th Floor
Cambridge, MA 02140
USA
Cambridge, MA 02140
USA
Phone
Website
Email Address
Overview
FoldRx is a leader in the discovery and development of first in class disease modifying drug therapies for diseases of protein misfolding and amyloidosis.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Richard Labaudiniere
Chief Medical Officer
Donna Grogan
Vice President
Bill Aliski
Vice President
Jeff Packman
Browse more venture capital transactions:
Prev: 9/1/2010: Celator Pharmaceuticals venture capital transaction
Next: 9/1/2010: Copiun venture capital transaction
Share this article
Where The Data Comes From
We do our best to record funding rounds that are announced publicly. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs